[1] 潘锋. 促进老年健康从疾病预防开始[J].中国医药导报, 2022, 19(24):1-4.
PAN F.Promoting the health of the elderly begins with disease prevention[J].China Medical Herald, 2022, 19(24):1-4.
[2] BARONE M, D’AMICO F, RAMPELLI S, et al.Age-related diseases, therapies and gut microbiome:A new frontier for healthy aging[J].Mechanisms of Ageing and Development, 2022, 206:111711.
[3] TARANTINI S, SUBRAMANIAN M, BUTCHER J T, et al.Revisiting adipose thermogenesis for delaying aging and age-related diseases:Opportunities and challenges[J].Ageing Research Reviews, 2023, 87:101912.
[4] ANWAR H, IFTIKHAR A, MUZAFFAR H, et al.Biodiversity of gut microbiota:Impact of various host and environmental factors[J].BioMed Research International, 2021, 2021:5575245.
[5] LI N, YAN F F, WANG N N, et al.Distinct gut microbiota and metabolite profiles induced by different feeding methods in healthy Chinese infants[J].Frontiers in Microbiology, 2020, 11:714.
[6] STOJANOV S, BERLEC A, ŠTRUKELJ B.The influence of probiotics on the firmicutes/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease[J].Microorganisms, 2020, 8(11):1715.
[7] MILLION M, RAOULT D.The role of the manipulation of the gut microbiota in obesity[J].Current Infectious Disease Reports, 2013, 15(1):25-30.
[8] HARAN J P, MCCORMICK B A.Aging, frailty, and the microbiome—How dysbiosis influences human aging and disease[J].Gastroenterology, 2021, 160(2):507-523.
[9] YOSHIMOTO S, MITSUYAMA E, YOSHIDA K, et al.Enriched metabolites that potentially promote age-associated diseases in subjects with an elderly-type gut microbiota[J].Gut Microbes, 2021, 13(1):1-11.
[10] HARAN J P, BUCCI V, DUTTA P, et al.The nursing home elder microbiome stability and associations with age, frailty, nutrition and physical location[J].Journal of Medical Microbiology, 2018, 67(1):40-51.
[11] KONTUREK P C, HAZIRI D, BRZOZOWSKI T, et al.Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases[J].Journal of Physiology and Pharmacology:an Official Journal of the Polish Physiological Society, 2015, 66(4):483-491.
[12] CONWAY J, DUGGAL N A.Ageing of the gut microbiome:Potential influences on immune senescence and inflammageing[J].Ageing Research Reviews, 2021, 68:101323.
[13] JACKSON M A, JEFFERY I B, BEAUMONT M, et al.Signatures of early frailty in the gut microbiota[J].Genome Medicine, 2016, 8(1):8.
[14] VOGT N M, KERBY R L, DILL-MCFARLAND K A, et al.Gut microbiome alterations in Alzheimer’s disease[J].Scientific Reports, 2017, 7(1):13537.
[15] ROMANO S, SAVVA G M, BEDARF J R, et al.Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation[J].NPJ Parkinson’s Disease, 2021, 7(1):27.
[16] CARDOSO M H, MENEGUETTI B T, OLIVEIRA-JÚNIOR N G, et al.Antimicrobial peptide production in response to gut microbiota imbalance[J].Peptides, 2022, 157:170865.
[17] MARSOOL M D M, VORA N, MARSOOL A D M, et al.Ulcerative colitis:Addressing the manifestations, the role of fecal microbiota transplantation as a novel treatment option and other therapeutic updates[J].Disease-a-Month, 2023, 69(11):101606.
[18] DAILEY F E, TURSE E P, DAGLILAR E, et al.The dirty aspects of fecal microbiota transplantation:A review of its adverse effects and complications[J].Current Opinion in Pharmacology, 2019, 49:29-33.
[19] MISHRA J, STUBBS M, KUANG L X, et al.Inflammatory bowel disease therapeutics:A focus on probiotic engineering[J].Mediators of Inflammation, 2022, 2022:9621668.
[20] TOEJING P, KHAMPITHUM N, SIRILUN S, et al.Influence of Lactobacillus paracasei HII01 supplementation on glycemia and inflammatory biomarkers in type 2 diabetes:A randomized clinical trial[J].Foods, 2021, 10(7):1455.
[21] MOBINI R, TREMAROLI V, STÅHLMAN M, et al.Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes:A randomized controlled trial[J].Diabetes, Obesity & Metabolism, 2017, 19(4):579-589.
[22] CANCELLO R, TURRONI S, RAMPELLI S, et al.Effect of short-term dietary intervention and probiotic mix supplementation on the gut microbiota of elderly obese women[J].Nutrients, 2019, 11(12):3011.
[23] IVEY K L, HODGSON J M, KERR D A, et al.The effect of yoghurt and its probiotics on blood pressure and serum lipid profile;a randomised controlled trial[J].Nutrition, Metabolism and Cardiovascular Diseases, 2015, 25(1):46-51.
[24] CICERO A F G, FOGACCI F, BOVE M, et al.Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients:A randomized placebo-controlled clinical trial[J].European Journal of Nutrition, 2021, 60(2):655-663.
[25] BELLIKCI-KOYU E, SARER-YUREKLI B P, KARAGOZLU C, et al.Probiotic kefir consumption improves serum apolipoprotein A1 levels in metabolic syndrome patients:A randomized controlled clinical trial[J].Nutrition Research, 2022, 102:59-70.
[26] ZAHARUDDIN L, MOKHTAR N M, NAWAWI K N M, et al.A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer[J].BMC Gastroenterology, 2019, 19(1):131.
[27] HUANG F, LI S J, CHEN W J, et al.Postoperative probiotics administration attenuates gastrointestinal complications and gut microbiota dysbiosis caused by chemotherapy in colorectal cancer patients[J].Nutrients, 2023, 15(2):356.
[28] FRANKO J, RAMAN S, PATEL S, et al.Survival and cancer recurrence after short-course perioperative probiotics in a randomized trial[J].Clinical Nutrition ESPEN, 2024, 60:59-64.
[29] PARK I J, LEE J H, KYE B H, et al.Effects of PrObiotics on the symptoms and surgical ouTComes after anterior REsection of colon cancer (POSTCARE):A randomized, double-blind, placebo-controlled trial[J].Journal of Clinical Medicine, 2020, 9(7):2181.
[30] TAMTAJI O R, HEIDARI-SOURESHJANI R, MIRHOSSEINI N, et al.Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer’s disease:A randomized, double-blind, controlled trial[J].Clinical Nutrition, 2019, 38(6):2569-2575.
[31] TON A M M, CAMPAGNARO B P, ALVES G A, et al.Oxidative stress and dementia in Alzheimer’s patients:Effects of synbiotic supplementation[J].Oxidative Medicine and Cellular Longevity, 2020, 2020:2638703.
[32] TAN A H, LIM S Y, CHONG K K, et al.Probiotics for constipation in parkinson disease:A randomized placebo-controlled study[J].Neurology, 2021, 96(5):e772-e782.
[33] IBRAHIM A, ALI R A R, MANAF M R A, et al.Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson’s disease:A randomised controlled trial[J].PLoS One, 2020, 15(12):e0244680.
[34] MEHRABANI S, KHORVASH F, HEIDARI Z, et al.The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson’s disease:A double-blind, placebo-controlled, randomized controlled trial[J].Journal of Functional Foods, 2023, 100:105397.
[35] HANDAJANI Y S, TURANA Y, YOGIARA Y, et al.Effects of tempeh probiotics on elderly with cognitive impairment[J].Frontiers in Aging Neuroscience, 2022, 14:891773.
[36] ALJUMAAH M R, BHATIA U, ROACH J, et al.The gut microbiome, mild cognitive impairment, and probiotics:A randomized clinical trial in middle-aged and older adults[J].Clinical Nutrition, 2022, 41(11):2565-2576.
[37] FEI Y Z, WANG R R, LU J C, et al.Probiotic intervention benefits multiple neural behaviors in older adults with mild cognitive impairment[J].Geriatric Nursing, 2023, 51:167-175.
[38] OLIVEIRA L V A, DOS SANTOS B N S, MACHADO Í E, et al.Prevalence of the metabolic syndrome and its components in the Brazilian adult population[J].Ciencia & Saude Coletiva, 2020, 25(11):4269-4280.
[39] SALARI A, GHODRAT S, GHEFLATI A, et al.Effect of kefir beverage consumption on glycemic control:A systematic review and meta-analysis of randomized controlled clinical trials[J].Complementary Therapies in Clinical Practice, 2021, 44:101443.
[40] FORD A L, NAGULESAPILLAI V, PIANO A, et al.Microbiota stability and gastrointestinal tolerance in response to a high-protein diet with and without a prebiotic, probiotic, and synbiotic:A randomized, double-blind, placebo-controlled trial in older women[J].Journal of the Academy of Nutrition and Dietetics, 2020, 120(4):500-516.e10.
[41] BELLIKCI-KOYU E, SARER-YUREKLI B P, AKYON Y, et al.Effects of regular kefir consumption on gut microbiota in patients with metabolic syndrome:A parallel-group, randomized, controlled study[J].Nutrients, 2019, 11(9):2089.
[42] 朱建丰, 徐英.益生菌对老年2型糖尿病患者的影响[J].中国微生态学杂志, 2021, 33(11):1299-1303.
ZHU J F, XU Y.Effects of probiotics on elderly patients with type 2 diabetes[J].Chinese Journal of Microecology, 2021, 33(11):1299-1303.
[43] 王丹萍, 徐珒昭, 张晓航, 等.糖尿病与宿主肠道菌群的关系及饮食介导的菌群调控作用研究进展[J].食品科学, 2023, 44(15):379-389.
WANG D P, XU J Z, ZHANG X H, et al.Progress in understanding the relationship between diabetes and host intestinal microbiota and diet-mediated microbiota regulation[J].Food Science, 2023, 44(15):379-389.
[44] BRITTON G J, CONTIJOCH E J, MOGNO I, et al.Microbiotas from humans with inflammatory bowel disease alter the balance of gut Th17 and RORγt+ regulatory T cells and exacerbate colitis in mice[J].Immunity, 2019, 50(1):212-224.e4.
[45] XU H Y, MA C, ZHAO F Y, et al.Adjunctive treatment with probiotics partially alleviates symptoms and reduces inflammation in patients with irritable bowel syndrome[J].European Journal of Nutrition, 2021, 60(5):2553-2565.
[46] FENG C J, ZHANG W Q, ZHANG T, et al.Oral administration of pasteurized probiotic fermented milk alleviates dextran sulfate sodium-induced inflammatory bowel disease in rats[J].Journal of Functional Foods, 2022, 94:105140.
[47] SHARMA S, BHATIA R, DEVI K, et al.A synbiotic combination of Bifidobacterium longum Bif10 and Bifidobacterium breve Bif11, isomaltooligosaccharides and finger millet Arabinoxylan prevents dextran sodium sulphate induced ulcerative colitis in mice[J].International Journal of Biological Macromolecules, 2023, 231:123326.
[48] AGRAIB L M, YAMANI M I, TAYYEM R, et al.Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients:A pilot, randomized, double-blind, placebo-controlled study[J].Clinical Nutrition ESPEN, 2022, 51:83-91.
[49] XIA Y J, CHEN Y, WANG G Q, et al.Lactobacillus plantarum AR113 alleviates DSS-induced colitis by regulating the TLR4/MyD88/NF-κB pathway and gut microbiota composition[J].Journal of Functional Foods, 2020, 67:103854.
[50] EMAMIE A D, RAJABPOUR M, GHANAVATI R, et al.The effects of probiotics, prebiotics and synbiotics on the reduction of IBD complications, a periodic review during 2009-2020[J].Journal of Applied Microbiology, 2021, 130(6):1823-1838.
[51] IYER N, CORR S C.Gut microbial metabolite-mediated regulation of the intestinal barrier in the pathogenesis of inflammatory bowel disease[J].Nutrients, 2021, 13(12):4259.
[52] SUGIHARA K, KAMADA N.Diet-microbiota interactions in inflammatory bowel disease[J].Nutrients, 2021, 13(5):1533.
[53] VIDIT K, PATEL A S.Geriatric assessments:Tools for every oncologist to stage the aging when caring for older adults with cancer[J].Advances in Oncology, 2022, 2(1):81-97.
[54] LIU G, CAO S G, LIU X D, et al.Effect of perioperative probiotic supplements on postoperative short-term outcomes in gastric cancer patients receiving neoadjuvant chemotherapy:A double-blind, randomized controlled trial[J].Nutrition, 2022, 96:111574.
[55] YUE Y C, YE K, LU J, et al.Probiotic strain Lactobacillus plantarum YYC-3 prevents colon cancer in mice by regulating the tumour microenvironment[J].Biomedicine & Pharmacotherapy, 2020, 127:110159.
[56] PANEBIANCO C, VILLANI A, PISATI F, et al.Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models[J].Biomedicine & Pharmacotherapy, 2022, 151:113163.
[57] GOCHER A M, WORKMAN C J, VIGNALI D A A.Interferon-γ:Teammate or opponent in the tumour microenvironment?[J].Nature Reviews.Immunology, 2022, 22(3):158-172.
[58] ABDOLALIPOUR E, MAHOOTI M, SALEHZADEH A, et al.Evaluation of the antitumor immune responses of probiotic Bifidobacterium bifidum in human papillomavirus-induced tumor model[J].Microbial Pathogenesis, 2020, 145:104207.
[59] GUHA D, BANERJEE A, MUKHERJEE R, et al.A probiotic formulation containing Lactobacillus bulgaricus DWT1 inhibits tumor growth by activating pro-inflammatory responses in macrophages[J].Journal of Functional Foods, 2019, 56:232-245.
[60] CHENG Y F, CHEN C, ZHANG F.Immunity orchestrates a bridge in gut-brain axis of neurodegenerative diseases[J].Ageing Research Reviews, 2023, 85:101857.
[61] NI Y H, YANG X, ZHENG L J, et al.Lactobacillus and Bifidobacterium improves physiological function and cognitive ability in aged mice by the regulation of gut microbiota[J].Molecular Nutrition & Food Research, 2019, 63(22):e1900603.
[62] XIAO J Z, KATSUMATA N, BERNIER F, et al.Probiotic Bifidobacterium breve in improving cognitive functions of older adults with suspected mild cognitive impairment:A randomized, double-blind, placebo-controlled trial[J].Journal of Alzheimer’s Disease:JAD, 2020, 77(1):139-147.
[63] BONFILI L, CECARINI V, BERARDI S, et al.Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels[J].Scientific Reports, 2017, 7(1):2426.
[64] LIU X, DU Z R, WANG X, et al.Polymannuronic acid prebiotic plus Lacticaseibacillus rhamnosus GG probiotic as a novel synbiotic promoted their separate neuroprotection against Parkinson’s disease[J].Food Research International, 2022, 155:111067.
[65] HSIEH T H, KUO C W, HSIEH K H, et al.Probiotics alleviate the progressive deterioration of motor functions in a mouse model of Parkinson’s disease[J].Brain Sciences, 2020, 10(4):206.
[66] LIAO J F, CHENG Y F, YOU S T, et al.Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced mouse models of Parkinson’s disease[J].Brain, Behavior, and Immunity, 2020, 90:26-46.
[67] CASTELLI V, D’ANGELO M, LOMBARDI F, et al.Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson’s disease models[J].Aging, 2020, 12(5):4641-4659.
[68] ALIPOUR NOSRANI E, TAMTAJI O R, ALIBOLANDI Z, et al.Neuroprotective effects of probiotics bacteria on animal model of Parkinson’s disease induced by 6-hydroxydopamine:A behavioral, biochemical, and histological study[J].Journal of Immunoassay & Immunochemistry, 2021, 42(2):106-120.
[69] YADAV H, JALDHI, BHARDWAJ R, et al.Unveiling the role of gut-brain axis in regulating neurodegenerative diseases:A comprehensive review[J].Life Sciences, 2023, 330:122022.
